Royal Bank of Canada
GHSI

Royal Bank of Canada’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Royal Bank of Canada’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed – – 7711
2023
Q3 		$0 Buy
+2
New +$15 ﹤0.01% 7743
2020
Q3 		– Sell
-13
Closed -$2K – 7014
2020
Q2 		$2K Buy
13
+6
+86% +$836 ﹤0.01% 6323
2020
Q1 		$1K Buy
+7
New +$740 ﹤0.01% 6519

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada's GHSI Position: Q4 2023 in Review

Royal Bank of Canada sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2023, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in GHSI in Q1 2020 and held it in 3 quarters. The position peaked at $2K in Q2 2020. 11 funds tracked by Wall St. Rank hold GHSI as of Q4 2023.

  • Royal Bank of Canada reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 2 Guardion Health Sciences, Inc. Common Stock shares in Q4 2023.
  • Royal Bank of Canada first reported a position in Guardion Health Sciences, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Royal Bank of Canada's Guardion Health Sciences, Inc. Common Stock position peaked at $2K in Q2 2020.
  • 11 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.